DIVISLAB — Divi's Laboratories Share News
0.000.00%
- IN₹3.04tn
- IN₹3.02tn
- IN₹105.60bn
Divi's Labs jumps after HSBC upgrade, Street-high PT
India's Divi's Labs jumps on signing supply deal with global pharma firm
India's Divi's Labs ends nearly 5% higher on upbeat Q4 results
India's Divi's Labs climbs on Q4 profit rise
Indian pharma stocks climb on 'not as bad as feared' Trump order
India's Divi's Labs gains as Citi hikes PT citing weight-loss drugs' prospects
India's Divi's Lab jumps on supply agreement, tops pharma index
India's drugmakers drop on uncertainty over US tariff threats
India's Divi's Lab gains again on Q3 print; analysts flag good execution, key risk
India's Divi's Labs beats Q3 profit estimates on strong API demand; shares rise
India's Divi's Labs gains on Q3 profit beat
Brief: Divi's Laboratories Starts Commercial Operations At Unit III In Andhra Pradesh
Indian drugmaker Anthem Biosciences files for $397 mln IPO (updated)
Indian Pharma firms gain in weak broader market as rupee hits record low
Brief: Divi's Labs Says Can Not Comment On Patent Lawsuits Of Big Pharma Companies And Its Impact
India's Divi's Labs falls on US court ruling for heart drug
Citi says Divi's Labs 'top pick' among Indian pharma sector; stock jumps
India's Glenmark Life gains after Kotak's double upgrade
India's Glenmark Life eyes worst day ever after downbeat Q2 results